Temsirolimus in Combination with Bendamustine and Rituximab (BeRT) for the Treatment of Relapsed Mantle Cell and Follicular Lymphoma: Final Phase I/II Results
暂无分享,去创建一个
M. Dreyling | P. Borchmann | G. Hess | M. Theobald | M. Witzens‐Harig | U. Keller | C. Medler | J. Atta | P. Larosee | C. A. Lerchenmuller | U. Bitz | Wagner Karola | A. Crombé | Christoph Medler | P. LaRosée